Pupillometer Market Updates

Pupillometer Market size was valued at USD 385.5 Million in 2023 and is poised to grow from USD 415.18 Million in 2024 to USD 751.64 Million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The global pupillometer market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'NeurOptics, Inc. ', 'Adaptica ', 'Essilor Instruments USA ', 'HAAG-STREIT GROUP ', 'Johnson & Johnson Vision ', 'Luneau Technology Group ', 'NIDEK CO., LTD. ', 'Reichert Technologies ', 'SCHWIND eye-tech-solutions ', 'US Ophthalmic ', 'Konan Medical ', 'Brightlamp, Inc. ', 'TOMEY Corporation ', 'Good-Lite Company ', 'FIM Medical ', 'Amtech Systems ', 'Kowa Company, Ltd.'

Efficient and reliable diagnostic devices like pupillometers are increasingly demanded by specialized clinics and hospitals for examining patients’ ocular health. This notably drives the demand for these effective devices in ophthalmic practices. Moreover, the growing cases of glaucoma are demanding pupillometers on a global scale. They play a crucial role in monitoring the condition of patients, helping them get timely guidance.

Handheld and Portable Devices: Handheld pupillometers are gaining huge prominence and preference for their easy usage and portability. This increases their suitability to be used in different settings like remote locations and emergency care settings. Also, the inclination towards decentralized healthcare is propelling the demand for diagnostic tools like pupillometers, allowing quick examinations in different clinical settings.

Region-wise, North America is the dominating region among others and is expected to lead over the forecast period owing to the improved healthcare infrastructure and growing cases of neurological disorders. North America brags about its well-developed healthcare infrastructure with easy access to superior healthcare technologies and services. This boosts the adoption of pupillometers in the region, impacting regional growth. The region also reports increased cases of neurological disorders and eye diseases, which demands advanced diagnostic tools in clinics. Furthermore, major investments in research and development by public and private sectors are encouraging the emergence of more advanced diagnostic devices. The leading players in the region include MediVision, iCare, Nidek Co., Ltd., Neuroptics, Inc., Canon Medical Systems, Optovue, Inc., and more.